New Research Provides Nutritional Solution for Children's Eye Health
Astaxanthin, a powerful antioxidant sourced from the microalgae Haematococcus pluvialis, is supported by extensive clinical research on ocular health in adults. Studies highlight its effectiveness in enhancing the eye's accommodative function and alleviating symptoms of visual strain. The ciliary muscles, responsible for the eye's ability to focus on near or distant objects, are susceptible to oxidative stress caused by prolonged near-vision tasks like screen use. Astaxanthin's antioxidant properties help mitigate this oxidative damage, supporting ciliary muscle performance and overall ocular health.
"Our goal was to clinically validate astaxanthin as an effective nutritional intervention for visual performance in school-aged children," stated
The study involved 64 children aged 10-14 years who reported a history of 4+ hours of daily digital device use. They received either 4 mg/day of AstaReal® Astaxanthin or a placebo over 3 months. Researchers assessed the effects of supplementation using subjective questionnaires and objective visual performance metrics. The children receiving astaxanthin reported significant improvements in eye fatigue and discomfort. The Astaxanthin group also showed improved tear production, which is commonly affected by prolonged screen usage.
This study underscores AstaReal® Astaxanthin as an effective and safe nutritional solution for managing Computer Vision Syndrome (CVS) in children. In today's digital age, where prolonged screen time for both education and recreation has become the norm, this offers a timely and valuable approach to supporting eye health.
About AstaReal Inc.
AstaReal Inc. is a manufacturer and supplier of the world's leading and most studied natural astaxanthin from algae supported by 160+ studies. AstaReal stands at the forefront of innovation in natural antioxidants.
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-research-provides-nutritional-solution-for-childrens-eye-health-302390474.html
SOURCE AstaReal Inc., USA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
- Sunshine Guojian Releases 2026 Interim Report:
- Canadian Banking Regulator Urged to Rethink Climate Risk Guideline says Friends of Science; Keystone XL could REcarbonize Canada
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share